Details

Last Funding Type

Series A

Last Funding Money Raised

$8M

Industries

Biotechnology,Emergency Medicine,Health Care,Information Technology

Founded date

Jan 1, 2015

Number Of Employee

11 - 50

Operating Status

Active

At Paragon Genomics, we develop and commercialize rapid, easy-to-use, ultra-high multiplex PCR-based target enrichment solutions for Next-Generation Sequencing (NGS). Our proprietary CleanPlex® background-removing technology enables NGS customers to develop targeted sequencing assays that are accurate, sensitive, and simple, yet cost effective. Our technology is applicable to many fast-growing NGS segments such as cancer research, liquid biopsy, biomarker discovery, genomics-guided breeding, companion diagnostics, and immunotherapy monitoring.